Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Mathilde, Cabart"'
Autor:
Diego Teyssonneau, Henri Margot, Mathilde Cabart, Mylène Anonnay, Paul Sargos, Nam-Son Vuong, Isabelle Soubeyran, Nicolas Sevenet, Guilhem Roubaud
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-19 (2021)
Abstract Despite survival improvements achieved over the last two decades, prostate cancer remains lethal at the metastatic castration-resistant stage (mCRPC) and new therapeutic approaches are needed. Germinal and/or somatic alterations of DNA-damag
Externí odkaz:
https://doaj.org/article/a59f9df956e7452d9f9fdade0d7452fd
Autor:
Jean Palussière, Vittorio Catena, Philippe Lagarde, Sophie Cousin, Mathilde Cabart, Xavier Buy, François Chomy
Publikováno v:
International Journal of Hyperthermia, Vol 36, Iss 2, Pp 46-52 (2019)
Non-small cell lung cancer (NSCLC) remains the leading cause of cancer death; percutaneous thermal ablation (TA) has proven feasibility, good local control and good tolerance in stage I tumors for patients with medical comorbidities and who are ineli
Externí odkaz:
https://doaj.org/article/5425cef5a4e14268b1a908744f7a9161
Autor:
Laurent Greillier, Manon Gauvrit, Elena Paillaud, Nicolas Girard, Coline Montégut, Rabia Boulahssass, Marie Wislez, Frédéric Pamoukdjian, Romain Corre, Mathilde Cabart, Philippe Caillet, Yaniss Belaroussi, Matthieu Frasca, Pernelle Noize, Pascal Wang, Soraya Mebarki, Simone Mathoulin-Pelissier, Anne-Laure Couderc
Publikováno v:
Cancers, Vol 14, Iss 3, p 769 (2022)
Systematic molecular profiling and targeted therapy (TKI) have changed the face of Non-Small Cell Lung Cancer (NSCLC) treatment. However, there are no specific recommendations to address the prescription of TKI for older patients. A multidisciplinary
Externí odkaz:
https://doaj.org/article/0ef89257e7364056acecffa304b8704b
Autor:
Lisenn Lalier, François M. Vallette, Jaafar Bennouna, Didier Decaudin, Ariel Savina, Fanny Bouquet, Ludmilla de Plater, Mathilde Cabart, Marie-Pierre Joalland, Judith Raimbourg
Supplementary figures and table described in the manuscript
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26114aac7ec37482a6d49c58fc84eb0d
https://doi.org/10.1158/1535-7163.22507992.v1
https://doi.org/10.1158/1535-7163.22507992.v1
Autor:
Alban Bessede, Florent Peyraud, Jean Philippe Guegan, Christophe Rey, Sylvestre Le Moulec, Fabrice Barlesi, Sophie Cousin, Guilhem Roubaud, Mathilde Cabart, Maxime Brunet, Ezogelin Gruyters, Ariel Savina, Berengère Dadone-Montaudon, Aurélien Marabelle, Jean Charles Soria, Yohann Loriot, Jean-Yves Scoazec, François Le Loarer, Antoine Italiano
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Laurent Greillier, Manon Gauvrit, Elena Paillaud, Nicolas Girard, Coline Montégut, Rabia Boulahssass, Marie Wislez, Frédéric Pamoukdjian, Romain Corre, Mathilde Cabart, Philippe Caillet, Yaniss Belaroussi, Matthieu Frasca, Pernelle Noize, Pascal Wang, Soraya Mebarki, Simone Mathoulin-Pelissier, Anne-Laure Couderc
Publikováno v:
Cancers
Cancers, 2022, 14 (3), ⟨10.3390/cancers14030769⟩
Cancers, MDPI, 2022, 14 (3), ⟨10.3390/cancers14030769⟩
Cancers, Vol 14, Iss 769, p 769 (2022)
Cancers, 2022, 14 (3), ⟨10.3390/cancers14030769⟩
Cancers, MDPI, 2022, 14 (3), ⟨10.3390/cancers14030769⟩
Cancers, Vol 14, Iss 769, p 769 (2022)
International audience; Systematic molecular profiling and targeted therapy (TKI) have changed the face of Non-Small Cell Lung Cancer (NSCLC) treatment. However, there are no specific recommendations to address the prescription of TKI for older patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::989d013930764c2dc5aacabadddf2693
https://hal.science/hal-03579482
https://hal.science/hal-03579482
Autor:
Pauline, Bertolaso, Véronique, Brouste, Anne-Laure, Cazeau, Henri, de Clermont-Gallerande, Franck, Bladou, Mathilde, Cabart, Felix, Lefort, Marine, Gross-Goupil
Publikováno v:
Clinical genitourinary cancer. 20(3)
Guidelines do not recommend FDG-PET CT for the staging of MIBC as a standard. The objectives of the study are to assess the accuracy of the FDG-PET CT for LN staging and to determine the rate of treatment modification according to FDG-PET CT results
Autor:
Florent Peyraud, Jean-Philippe Guegan, Christophe Rey, Sophie Cousin, Guilhem Roubaud, Mathilde Cabart, Maxime Brunet, Ezogelin Oflazoglu Gruyters, Ariel Savina, Sylvestre Le Moulec, Bérangère Dadone-Montaudon, Fabrice Barlesi, Benjamin Besse, Yohann Loriot, Aurelien Marabelle, Jean-Charles Soria, Jean-Yves Scoazec, François Le Loarer, Alban Bessede, Antoine Italiano
Publikováno v:
Journal of Clinical Oncology. 40:2596-2596
2596 Background: Given that most of cancer patients treated with anti-PD1/PD-L1 immune checkpoint blockers (ICB) do not derive benefit, there is a crucial need to identify reliable predictive biomarker of response. Besides PD-1, several key immune ch
Autor:
Pauline Bertolaso, Véronique Brouste, Anne-Laure Cazeau, Henri de Clermont-Gallerande, Franck Bladou, Mathilde Cabart, Felix Lefort, Marine Gross-Goupil
Publikováno v:
Clinical Genitourinary Cancer. 20:297-297.e6
Autor:
Alban Bessede, Aurelien Marabelle, Jean-Philippe Guegan, Florent Peyraud, François-Xavier Danlos, Sophie Cousin, Nathalie Chaput, Mariella Spalato, Guilhem Roubaud, Mathilde Cabart, Mohamed Khettab, Assia Chaibi, Christophe Rey, Imane Nafia, François-Xavier Mahon, Jean-Charles Soria, Antoine Italiano
Publikováno v:
Journal of Clinical Oncology. 40:12000-12000
12000 Background: Pain is the most common symptom experienced by patients with advanced cancer. Acetaminophen (APAP, commonly known as paracetamol) alone or in combination with a weak opioid, such as codeine or tramadol, is usually considered as the